14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $7.97 $10.47 Wednesday, 1st May 2024 ZYME stock ended at $8.76. This is 2.10% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.26% from a day low at $8.55 to a day high of $9.00.
90 days $7.97 $13.14
52 weeks $6.02 $13.14

Historical Zymeworks Inc prices

Date Open High Low Close Volume
May 16, 2017 $13.19 $13.21 $13.00 $13.00 21 942
May 15, 2017 $13.00 $13.32 $13.00 $13.11 24 829
May 12, 2017 $13.09 $13.12 $13.00 $13.00 5 444
May 11, 2017 $13.10 $13.10 $13.05 $13.09 19 341
May 10, 2017 $13.03 $13.09 $13.00 $13.09 13 474
May 09, 2017 $13.00 $13.05 $13.00 $13.00 72 822
May 08, 2017 $13.13 $13.13 $13.00 $13.03 11 444
May 05, 2017 $13.16 $13.20 $13.00 $13.05 20 538
May 04, 2017 $13.34 $13.50 $13.00 $13.11 33 256
May 03, 2017 $13.10 $13.40 $13.10 $13.28 40 809
May 02, 2017 $13.00 $13.19 $13.00 $13.10 68 578
May 01, 2017 $13.20 $13.20 $13.00 $13.07 97 009
Apr 28, 2017 $13.50 $14.25 $13.00 $13.00 953 887
Click to get the best stock tips daily for free!

About Zymeworks Inc

Zymeworks Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ... ZYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT